To test whether the observed differences in ctDNA VAFs, cfDNA concentration and CEA levels depending on the course of disease are statistically significant, all three markers were compared between samples collected at baseline, during the course of disease with clinically evident tumor, and during follow-up after curative treatment. Here, CEACAM5 is linked to neoplasm.